Epizyme Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
68,482.00
41,411.00
2,560.00
8,007.00
10,000.00
21,700
SG&A Expense
70,906.00
95,719.00
133,690.00
118,244.00
145,203.00
148,753
EBIT
3,127.00
55,050.00
132,549.00
111,826.00
136,842.00
128,105
Non Operating Income/Expense
81.00
59.00
79.00
83.00
32.00
25
Pretax Income
3,134.00
54,896.00
132,376.00
110,212.00
134,645.00
123,573
Income Tax
349.00
109.00
-
-
336.00
57
Consolidated Net Income
3,483.00
55,005.00
132,376.00
110,212.00
134,309.00
123,630
Net Income
3,483.00
55,005.00
132,376.00
110,212.00
134,309.00
123,630
Net Income After Extraordinaries
3,483.00
55,005.00
132,376.00
110,212.00
134,309.00
123,630
Net Income Available to Common
3,747.00
55,005.00
132,376.00
110,212.00
134,309.00
123,630
EPS (Basic)
0.22
1.67
3.32
1.93
2.18
1.72
Basic Shares Outstanding
17,049.00
33,027.00
39,839.00
57,126.00
61,471.00
71,864
EPS (Diluted)
0.22
1.67
3.32
1.93
2.18
1.72
Diluted Shares Outstanding
17,049.00
33,027.00
39,839.00
57,126.00
61,471.00
71,864
EBITDA
2,424.00
54,308.00
131,130.00
110,237.00
135,203.00
127,053
Non-Operating Interest Income
74.00
95.00
94.00
1,531.00
2,165.00
4,557
Preferred Dividends
264.00
-
-
-
-
-
About Epizyme
View Profile
